
Bristol Myers Squibb statistics
$63.43+1.78%Close 13 Nov 2026 · Market value $128.5B
Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.
Valuation
Bristol Myers Squibb is valued at $128.5B on its latest close. Its price is 13.9 times its earnings.
| Market value | $128.5B |
|---|
| Enterprise value | $162.7B |
|---|
| Price / earnings | 13.91 |
|---|
| Price / sales | 2.57 |
|---|
| Price / book | 5.49 |
|---|
| EV / EBITDA | 11.31 |
|---|
| EV / sales | 3.25 |
|---|
| Price / free cash flow | 13.84 |
|---|
| Price / free cash flow, own 5-year average | 9.54 |
|---|
| EV / EBIT | 13.98 |
|---|
| EV / free cash flow | 17.39 |
|---|
| Free cash flow yield | 7.2% |
|---|
| Dividend yield | 4.0% |
|---|
Share price
| Latest close | $63.43 |
|---|
| Day's change | +1.8% |
|---|
| 52-week high | $68.64 |
|---|
| 52-week low | $45.27 |
|---|
| From 52-week high | −7.6% |
|---|
| Return · 1 month | +6.2% |
|---|
| Return · 3 months | −3.1% |
|---|
| Return · year to date | +17.6% |
|---|
| Return · 1 year | +29.2% |
|---|
| Beta · 1 year against the S&P 500 | 0.23 |
|---|
| 50-day average | $61.90 |
|---|
| 200-day average | $60.34 |
|---|
| RSI 14 | 55.8 |
|---|
| Average volume · 20 sessions | 10.1M |
|---|
Margins and returns
For fiscal 2025, as filed.
| Gross margin | 71.1% |
|---|
| Operating margin | 20.8% |
|---|
| Net margin | 14.6% |
|---|
| Free cash flow margin | 26.7% |
|---|
| Return on equity | 40.5% |
|---|
| Return on assets | 8.3% |
|---|
| Return on invested capital | 11.5% |
|---|
| Return on invested capital, 5-year average | 5.5% |
|---|
| Return on capital employed | 14.8% |
|---|
| Stock-based compensation / revenue | 1.1% |
|---|
Financial position
At the end of fiscal 2025.
| Cash and equivalents | $10.21B |
|---|
| Total debt | $49.12B |
|---|
| Net debt | $38.44B |
|---|
| Current ratio | 1.26 |
|---|
| Quick ratio | 1.16 |
|---|
| Debt / equity | 2.66 |
|---|
| Net debt / EBITDA | 2.74 |
|---|
| Interest coverage | 5.29 |
|---|
Growth
| Revenue, latest quarter on a year | +6.9% |
|---|
| Revenue, twelve months on a year | +4.2% |
|---|
| EPS, latest quarter on a year | −2.8% |
|---|
| EPS, twelve months on a year | +52.3% |
|---|
| Revenue, 5-year compound | +2.5% |
|---|
| Revenue, 10-year compound | +11.3% |
|---|
| Free cash flow, 5-year compound | −0.7% |
|---|
Shares and dividends
For fiscal 2025, as filed.
| Diluted shares | 2.0B |
|---|
| Shares outstanding, 5-year compound | −2.0% |
|---|
| Net share repurchases | $0.00 |
|---|
| Dividends per share | $2.49 |
|---|
| Dividend payout | 71.5% |
|---|
Taxes
For fiscal 2025, as filed.
| Income tax expense | $2.27B |
|---|
| Effective tax rate | 24.4% |
|---|
BMY in the terminal
Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.